Advanced search Help
Searching for terms: EXACT: "COVID 19 Resources" in: series
Clear all search criteria
Only 2/3! You are seeing results from the Public Collection, not the complete Full Collection. Sign in to search everything (see eligibility).
-
U.S. Repatriation Program for Citizens Returned from Abroad [March 31, 2020]
From the Introduction: "Section 1113 of the Social Security Act (42 U.S.C. §1313) permanently authorizes the Department of Health and Human Services (HHS) to provide temporary aid to certain repatriated U.S. citizens and their dependents. Eligible citizens must (1) be without available resources 'and' (2) be identified by the Department of State (DOS) as having returned (or been brought) from a foreign country because the citizen was destitute, because the citizen (or dependent) was ill, or because of war, threat of war, invasion, or a similar crisis. Temporary aid is generally provided as a loan. The Social Security Amendments of 1961 (P.L. 87- 64) established the program, following the repatriation of a 'substantial number of American citizens from Cuba' (S.Rept. 87-425). Jurisdiction has traditionally been exercised by the House Ways and Means Committee and the Senate Finance Committee."
Library of Congress. Congressional Research Service
Lynch, Karen E.
2020-03-31
-
Closing the Gap on Critical Medical Supplies: 4 Lines of Effort Leveraging the Strength of the Whole Community [infographic]
This infographic supports the "Closing the Gap on Critical Medical Supplies: 4 Lines of Effort Leveraging the Strength of the Whole Community" fact sheet and details FEMA's approach to stabilizing critical resource supply lines.
United States. Federal Emergency Management Agency
2020-03-31?
-
DEA and SAMHSA Buprenorphine and Telemedicine COVID-19 Guidance
From the Document: "In light of the nationwide public health emergency declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, as a result of the Coronavirus Disease 2019 (COVID19), the Drug Enforcement Administration (DEA) is exercising its authorities to provide flexibility in the prescribing and dispensing of controlled substances to ensure necessary patient therapies remain accessible. As part of this effort, DEA has partnered with the Substance Abuse and Mental Health Services Administration (SAMHSA) to ensure authorized practitioners may admit and treat new patients with opioid use disorder (OUD) during the public health emergency. DEA has already announced that practitioners may prescribe controlled substances to patients using telemedicine without first conducting an in-person evaluation during this public health emergency under 21 U.S.C. 802(54)(D). Today, DEA notes that practitioners have further flexibility during the nationwide public health emergency to prescribe buprenorphine to new and existing patients with OUD via telephone by otherwise authorized practitioners without requiring such practitioners to first conduct an examination of the patient in person or via telemedicine. This additional flexibility under which authorized practitioners may prescribe buprenorphine to new patients on the basis of a telephone evaluation is in effect from March 31, 2020, until the public health emergency declared by the Secretary ends, unless DEA specifies an earlier date."
United States. Drug Enforcement Administration
Prevoznik, Thomas W.
2020-03-31
-
Resilience Analysis and Planning Tool
From the Document: "The Resilience Analysis and Planning Tool (RAPT) is a geographic information systems (GIS) tool to help emergency managers and community partners at all GIS skill levels to visualize and assess potential challenges to community resilience. This User Guide provides in-depth information on RAPT functionality and step-by-step instructions on how to use all the features."
United States. Federal Emergency Management Agency
2020-03-31
-
Coronavirus and the Cities: Explaining Variations in the Onset of Infection and in the Number of Reported Cases and Deaths in U.S. Metropolitan Areas as of 27 March 2020
From the Introduction: "We can now begin to explain the geographic variations in the date of the onset of infections, in the number of confirmed cases, and in the number of deaths from the Coronavirus. Instead of focusing on states or on counties, we focus on cities, and more specifically on Metropolitan Statistical Areas (MSAs) in the United States. [...] The question that many of us are asking is 'why do some U.S. metropolitan areas have more infections and more deaths than others?' A number of conjectures have been advanced. The governor of the state of New York, Andrew Cuomo, for example, conjectured on 26 March that New York has more cases than any other city because it is dense and because it is an international gateway. This is a hypothesis that can now be tested with data. We have tried to answer three related questions: [1] Why did some cities encounter Coronavirus infections earlier than others? [2] Why do some cities have more confirmed cases of Coronavirus infections than others? [and 3] Why do some cities have more deaths from the Coronavirus than others?"
New York University. Marron Institute of Urban Management
Angel, Shlomo; Blei. Alejandro M.; Lamson-Hall, Patrick . . .
2020-03-31
-
COVID-19: Regulator Guidance on Privacy and Cybersecurity Issues Raised as Companies Respond to the Pandemic [UPDATE 2]
From the Document: "The Coronavirus (COVID-19) pandemic has given rise to unprecedented challenges for organizations of all shapes and sizes, from world governments and health care systems to local restaurants and retailers. As companies seek to navigate a path forward, privacy and data security concerns have become a central issue. For example, many companies are facing difficult questions about how to ensure they are complying with applicable privacy laws while also being transparent with employees, customers, and the public. Concurrently, hackers and other bad actors are taking advantage of the crisis to spread their own kinds of viruses and malware to infect and disrupt company systems and gain access to sensitive information."
Willkie, Farr & Gallagher
Mondoloni, Dominique; Alvarez, Daniel K.; Bower, Elizabeth . . .
2020-03-31
-
COVID-19: Guidance for Governments Assessing Treatments
From the Executive Summary: "1. What drugs are or will be available to treat Covid-19 [coronavirus disease 2019]? [a] Therapeutic treatments for Covid-19 should be considered after (1) prevention measures that reduce disease transmission; and (2) supportive care measures (such as ventilators and medical oxygen) that manage the symptoms of Covid-19. [b] While there is currently no treatment for Covid-19, nor any robust clinical evidence that supports a particular treatment, many clinical trials are underway to assess potential treatments. WHO [World Health Organization] has launched the Solidarity Trial to assess the four most promising treatments. [c] Treatments, if approved, are unlikely to be life-saving, but more likely to have an impact on the early stage of the disease. [d] Governments should also develop a vaccine strategy to access vaccine supplies when one is proven."
Tony Blair Institute for Global Change
2020-03-31
-
COVID-19: Testing, Screening and Tracing
From the Document: "Screening has four basic purposes. Screening and triage protocols and methods, from ad hoc passive screening to mass, indiscriminate testing, vary widely. Regardless, the purpose of screening remains the same: (i) support risk communications to individuals; (ii) generate real-time data; (iii) enable acuity-based triage; and (iv) support proactive case finding and contact tracing early on. [...] Importance of testing: Testing enables containment and informs broader policy decisions. [...] Contact tracing is a monitoring process that is central to fighting infectious disease outbreaks. The World Health Organization breaks it down into three basic steps: [1] Identifying someone who has the disease. [2] Listing those who have come into contact with the person. [3] Monitoring and following up with those people."
Tony Blair Institute for Global Change
2020-03-31
-
COVID-19 Equipamento Médico e Abastecimento Alimentar
"A avaliação rápida das necessidades e das oportunidades de aprovisionamento é fundamental para lidar com as limitações cada vez maiores da cadeia de abastecimento."
Tony Blair Institute for Global Change
2020-03-31
-
COVID-19 - Teste, Rastreio e Identificação de Contactos 101
"O rastreio tem quatro objetivos básicos. Os protocolos e métodos de rastreio e triagem, desde o rastreio passivo ad hoc até ao rastreio em massa, passando pela realização indiscriminada de testes, variam bastante. Contudo, os objetivos do rastreio continuam a ser os mesmos: (i) apoiar a comunicação do risco às pessoas; (ii) gerar dados em tempo real; (iii) permitir a triagem com base no grau de gravidade; e (iv) apoiar uma abordagem proativa à identificação de casos e dos contactos numa fase precoce. [...] A importância dos testes: os testes contribuem para a contenção e ajudam à tomada de decisões de políticas mais gerais. [...] A identificação dos contactos é um processo de monitorização que é fundamental para a luta de surtos de doenças infeciosas. A Organização Mundial para a Saúde divide-o em três passos básicos: [1] Identificar uma pessoa com a doença. [2] Fazer uma lista dos indivíduos que entraram em contacto com essa pessoa. [3] Fazer a monitorização e acompanhamento desses indivíduos."
Tony Blair Institute for Global Change
2020-03-31
-
Learning from Past Pandemics: Bridging the Science Gap [video]
From the Webpage: "The third installment in the Dart Center for Journalism and Trauma / Columbia Journalism Review's 'Reporting and Covid-19: Conversations for Journalists' webinar series. Guest: Caleb Hellerman, Documentary filmmaker, longtime supervising producer to Dr. Sanjay Gupta and CDC [Centers for Disease Control and Prevention] Fellow. As journalists, how can we best develop the right expert sources? How can we effectively bridge complicated medical science and public understanding?"
Dart Center for Journalism & Trauma
Hellerman, Caleb; Shapiro, Bruce
2020-03-31
-
COVID-19: Good Practice for Surgeons and Surgical Teams
From the Introduction: "As healthcare systems around the world are prepared to operate at more than maximum capacity for a number of months during the COVID-19 [coronavirus disease] outbreak, several adjustments in surgical services will be required. This guide brings together a series of recommendations drawing from existing College guidance and recently published literature on COVID-19 from national and international bodies to support surgeons and surgical teams as they respond to the outbreak. In these exceptional circumstances, we recognise that hospitals and surgical units will have to make complex decisions very quickly. Our aim is not to be overly prescriptive, but to make broad recommendations which can be adapted to support individual circumstances based on surgeons' and teams' professional judgement. Our recommendations are structured around four areas."
Royal College of Surgeons of England
2020-03-31
-
Preventing the Spread of COVID-19 in Retirement Communities and Independent Living Facilities (Interim Guidance)
From the Document: "This guidance is for owners, administrators, operators, workers, volunteers, visitors, and residents of retirement communities and ILF [independent living facilities] that are not healthcare facilities."
Centers for Disease Control and Prevention (U.S.)
2020-03-31
-
Drinking Water and Novel Coronavirus Disease (COVID-19)
From the Document: "COVID-19 is a respiratory disease caused by a new, or 'novel' coronavirus. COVID-19 is short for Coronavirus Disease 2019. Washington State is currently experiencing a COVID-19 outbreak. COVID-19 has not been detected in drinking water. The Office of Drinking Water at the Washington State Department of Health and public water system operators work every day to protect public water supplies from bacteriological and viral contamination. Drinking water regulations use a multi-barrier approach to ensure safe and reliable drinking water."
Washington (State). Department of Health
2020-03-31
-
Coronavirus Pandemic: Addressing Weaknesses in the Medical Supply Chain [webinar]
From the Webpage: "Despite efforts to ramp up testing for COVID-19 [coronavirus disease], gaps persist in assessing the severity of the coronavirus pandemic, impacted by a stressed global medical supply chain. With the possibility of future waves of the virus, what do researchers and health care professionals need most to continue fighting spread of the COVID-19? In this Q&A [Question and Answer session], epidemiologist Michael Mina updated our viewers on the scope of the pandemic and our understanding of the virus; described the intersection between research and supply chains; and explored hopes for treatments and vaccines. The World's Elana Gordon moderated."
Harvard School of Public Health; Public Radio International
Mina, Michael; Gordon, Elana
2020-03-31
-
Contact Tracing: Public Health Management of Persons, Including Healthcare Workers, Having Had Contact with COVID-19 Cases in the European Union - First Update
From the Scope: "This document aims to help EU/EEA [European Union/ European Economic Area] public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 [coronavirus disease] cases."
European Centre for Disease Prevention and Control
2020-03-31
-
Monterey County Daily Situation Report [March 31, 2020]
From the Document: "Novel Coronavirus is an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and which has now been detected in more than 100 locations internationally, including in the United States. The virus has been named 'SARS-CoV-2' and the disease it causes has been named 'coronavirus disease 2019' (abbreviated 'COVID-19'). 11:59pm, March 29, 2020, there have been 40 confirmed cases and 561 tests of COVID-19 among Monterey County residents."
Monterey County (Calif.). Health Department
McKee, Charles; Malais, Gerry; Moreno, Edward . . .
2020-03-31
-
Infection Prevention and Control and Preparedness for COVID-19 in Healthcare Settings: Second Update - 31 March 2020
From the Scope: "This document aims to provide guidance to EU/EEA [European Union/European Economic Area] healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 [coronavirus disease] infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA. This is an update of the ECDC [European Centre for Disease Prevention and Control] guidance dated 12 March 2020 'Infection prevention and control for COVID-19 in healthcare settings'. This update focuses on measures to be applied in settings with increasing community transmission, a growing demand for care of COVID-19 patients and ensuing staff issues in the event of shortages of personal protective equipment (PPE) for healthcare facilities in EU/EEA countries and the United Kingdom."
European Centre for Disease Prevention and Control
2020-03-31
-
Optimizing Ventilator Use During the COVID-19 Pandemic
From the Document: "The COVID-19 outbreak is presenting unprecedented challenges to our health care system. According to our best projections, combined with information on the ground, the availability of precious medical resources will be limited because of the numbers of patients and their severity of illness. Among the most important resources will be mechanical ventilators, affiliated gases and disposables, and of course, qualified professionals to operate these devices. In order to meet the growing demand, it is essential that we aggressively implement the following four overall measures: [1] Rigorous adherence to all social distancing measures, including limitations on gatherings and travel. [...2] Guidelines to optimize the use of mechanical ventilators. [...3] Judicious, data driven requests and usage of the Strategic National Stockpile [SNS] of ventilators and equipment. [...and 4] Increasing the capacity of the SNS through federal procurement."
United States. Public Health Service
2020-03-31
-
Running Ahead of Pandemics: Achieving in-Advance Antiviral Drugs
"Three months into the COVID-19 [coronavirus disease] outbreak caused by a novel strain of coronavirus (SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] ), the world is still in search of an effective therapeutic drug. Experimental drugs developed for other infections, such as Gilead's remdesivir, have been repurposed with unclear success. A recent small study suggests that hydroxychloroquine and azithromycin used in combination may speed up recovery. However, if any of these repurposed drugs prove effective, it will be a matter of good fortune, not good preparedness. We must shift from the hope of 'just-in-time drugs' toward the promise of 'in-advance' therapeutics by developing broad-spectrum drugs."
Mercatus Center
Pannu, Jassi
2020-03-31
-
Guidance for Laboratories Shipping Specimens to WHO Reference Laboratories That Provide Confirmatory Testing for COVID-19 Virus
From the Background: "WHO [World Health Organization] has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 [coronavirus disease] from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVID-19. Instructions are outlined in this guidance document."
World Health Organization
2020-03-31
-
Prediction Models for Diagnosis and Prognosis of COVID-19 Infection: Systematic Review and Critical Appraisal
From the Abstract Objective: "To review and critically appraise published and preprint reports of prediction models for diagnosing coronavirus disease 2019 (covid-19) in patients with suspected infection, for prognosis of patients with covid-19, and for detecting people in the general population at risk of being admitted to hospital for covid-19 pneumonia."
BMJ Publishing Group
Wynants, Laure; Van Calster, Ben; Bonten, Marc J. M. . . .
2020-03-31
-
Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)
From the Document: "Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2 [severe acute respiratory syndrome-coronavirus-2]. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens form patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be altered to ensure proper specimens handling. General and specific biosafety guidelines for handling SARS-CoV-2 are provided [in this document]."
Centers for Disease Control and Prevention (U.S.)
2020-03-31
-
March 31, 2020: Interviews with Sheriffs About Jails and Officer Wellness
This is the March 31, 2020 Daily COVID-19 (coronavirus disease 2019) report from the Police Executive Research Forum (PERF).
Police Executive Research Forum
2020-03-31
-
Coronavirus (COVID-19) Pandemic: Private Nonprofit Organizations
From the Document: "All 50 states, the District of Columbia, five territories, and numerous tribes are working directly with FEMA under President Trump's March 13, 2020, nationwide emergency declaration for COVID-19 [coronavirus disease 2019]. Under this emergency declaration, and subsequent major disaster declarations, certain private non-profit (PNP) organizations are eligible to apply for funding through FEMA's Public Assistance program. This fact sheet provides guidance for determining the eligibility of PNP applicants and work performed in accordance with the COVID-19 emergency and major disaster declarations."
United States. Federal Emergency Management Agency
2020-03-31
-
Coronavirus Disease 2019 (COVID-19) Situation Report - 71
From the Highlights: "No new countries/territories/areas reported cases of COVID-19 [coronavirus disease 2019] in the past 24 hours. [2] As mentioned by the Director-General in his regular media briefing yesterday, ensuring free movement of essential health products is vital for saving lives and curbing the social and economic impacts of the pandemic. WHO [World Health Organization] is working intensively with partners to increase access to life-saving products, including diagnostics, PPE [personal protective equipment], medical oxygen, ventilators and more. [...3] Operations support and logistics continues to monitor critical markets and in partnership with the Pandemic Supply Chain Network, has increased engagement and coordination with private companies. Since the beginning of the outbreak, OSL [Operations Support and Logistics] has shipped more than 800 000 surgical masks, 54 000 N95 masks, 873 000 gloves, 15 000 goggles and 24 000 face shields to 75 countries. OSL has also shipped COVID-19 testing kits to 126 countries."
World Health Organization
2020-03-31
-
Master Question List for COVID-19 (Caused by SARS-CoV-2) Weekly Report [31 March 2020]
From the Foreword: "The Master Question List (MQL) is intended to quickly present the current state of available information to government decision makers in the operational response to COVID-19 [coronavirus disease 2019] and allow structured and scientifically guided discussions across the federal government without burdening them with the need to review scientific reports, and to prevent duplication of efforts by highlighting and coordinating research. The information contained in the following table has been assembled and evaluated by experts from publicly available sources to include reports and articles found in scientific and technical journals, selected sources on the internet, and various media reports. It is intended to serve as a 'quick reference' tool and should not be regarded as comprehensive source of information, nor as necessarily representing the official policies, either expressed or implied, of the DHS or the U.S. Government. DHS does not endorse any products or commercial services mentioned in this document. All sources of the information provided are cited so that individual users of this document may independently evaluate the source of that information and its suitability for any particular use. This document is a 'living document' that will be updated as needed when new information becomes available."
United States. Department of Homeland Security. Science and Technology Directorate
2020-03-31
-
Federal Reserve: Recent Actions in Response to COVID-19 [Updated March 31, 2020]
From the Document: "Coronavirus (COVID-19) has created significant economic disruption. In response, the Federal Reserve (Fed) has taken a number of steps to promote economic and financial stability involving the Fed's monetary policy and 'lender of last resort' roles. Some of these actions are intended to stimulate economic activity by reducing interest rates and others are intended to provide liquidity to financial markets so that firms have access to needed funding."
Library of Congress. Congressional Research Service
Labonte, Marc
2020-03-31
-
Business Interruption Insurance and COVID-19 [March 31, 2020]
From the Document: "The economic disruption from the COVID-19 [coronavirus disease 2019] pandemic has led businesses and policymakers to ask whether insurance should cover associated losses. The loss of income from mandatory or voluntary closures, supply chain disruptions, and reduced demand due to social distancing measures may induce businesses of all sizes to seek compensation from insurers."
Library of Congress. Congressional Research Service
Horn, Diane P.; Webel, Baird
2020-03-31
-
COVID-19: The Employee Retention Tax Credit [March 31, 2020]
From the Document: "The Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) includes an employee retention payroll tax credit intended to help businesses retain employees during the Coronavirus disease 2019, or COVID-19, public health emergency. Employee retention remains a policy concern, as a number of economic sectors have announced layoffs resulting from the COVID-19 induced economic fallout. Unemployment insurance claims have surged following these widespread layoffs. This Insight summarizes the employee retention tax credit in the CARES Act, makes comparisons to previous employee retention tax credits enacted as disaster tax relief, and highlights some economic and policy considerations."
Library of Congress. Congressional Research Service
Sherlock, Molly F.
2020-03-31
